JAZZ vs MGPI · P/E 1988, rev $2.28B vs rev $536.4M
Jazz Pharmaceuticals PLC (JAZZ) versus MGP Ingredients Inc (MGPI) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
MGP Ingredients Inc (MGPI) is a beverages - wineries & distilleries company listed on NASDAQ.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported MGPI revenue for 2025-12-31 was $536.4M. Net income was -$107.8M. Revenue was down 23.8% from 2024-12-31 to 2025-12-31. MGPI currently screens at market cap $336.8M.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. MGPI currently screens at market cap $336.8M.
Not investment advice. Open the JAZZ and MGPI stock pages for the full models.
Not investment advice.